Some studies have shown elevated pro-inflammatory cytokines (IL-6, TNF-α) and decreased anti-inflammatory cytokine IL-10 in patients with IBS (Mitselou et al. 2020; Kumar et al. 2022), while others have shown no difference between patients with IBS and healthy controls (Kamp et al. 2021). This evidence concerns the gene IL6 and irritable bowel syndrome.